Identification of Subtype-Specific Vulnerabilities in Resistant Glioblastoma: A Computational Pipeline for Biomarkers and Drug Discovery

Johan Sebastian Lopez-Parra, Fatima Hameedat, Sérgio F. Sousa, Annemiek M. E. Walenkamp, Flávia Sousa, Hélder A Santos

Open source

DOI
10.1021/acs.molpharmaceut.5c01538
Published
2025-12-02
Container
Molecular Pharmaceutics
Publisher
American Chemical Society (ACS)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acs.molpharmaceut.5c01538,
  title = {Identification of Subtype-Specific Vulnerabilities in Resistant Glioblastoma: A Computational Pipeline for Biomarkers and Drug Discovery},
  author = {Johan Sebastian Lopez-Parra and Fatima Hameedat and Sérgio F. Sousa and Annemiek M. E. Walenkamp and Flávia Sousa and Hélder A Santos},
  year = {2025},
  journal = {Molecular Pharmaceutics},
  doi = {10.1021/acs.molpharmaceut.5c01538},
  url = {https://doi.org/10.1021/acs.molpharmaceut.5c01538}
}

RIS

TY  - JOUR
TI  - Identification of Subtype-Specific Vulnerabilities in Resistant Glioblastoma: A Computational Pipeline for Biomarkers and Drug Discovery
AU  - Johan Sebastian Lopez-Parra
AU  - Fatima Hameedat
AU  - Sérgio F. Sousa
AU  - Annemiek M. E. Walenkamp
AU  - Flávia Sousa
AU  - Hélder A Santos
PY  - 2025
JO  - Molecular Pharmaceutics
DO  - 10.1021/acs.molpharmaceut.5c01538
UR  - https://doi.org/10.1021/acs.molpharmaceut.5c01538
ER  - 

APA

Lopez-Parra, J. S., Hameedat, F., Sousa, S. F., Walenkamp, A. M. E., Sousa, F., & Santos, H. A. (2025). Identification of Subtype-Specific Vulnerabilities in Resistant Glioblastoma: A Computational Pipeline for Biomarkers and Drug Discovery. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01538

Source records